参考文献/References:
[1] Biondi B,Kahaly GJ,Robertson RP.Thyroid dysfunction and diabetes mellitus:two closely associated disorders[J].Endocr Rev,2019,40(3):789-824.DOI:10.1210/er.2018-00163.
[2] 刘丹,徐书杭,陈国芳,等.甲状腺激素对胰岛β细胞功能的调控[J].国际内分泌代谢杂志,2014,34(1):18-21.DOI:10.3760/cma.j.issn.1673-4157.2014.01.005.
[3] Chen C,Xie Z,Shen Y,et al.The roles of thyroid and thyroid hormone in pancreas:physiology and pathology[J].Int J Endocrinol,2018,2018:2861034.DOI:10.1155/2018/2861034.
[4] Aïello V,Moreno-Asso A,Servitja JM,et al.Thyroid hormones promote endocrine differentiation at expenses of exocrine tissue[J].Exp Cell Res,2014,322(2):236-248.DOI:10.1016/j.yexcr.2014.01.030.
[5] Aguayo-Mazzucato C,DiIenno A,Hollister-Lock J,et al.MAFA and T3 drive maturation of both fetal human islets and insulin-producing cells differentiated from hESC[J].J Clin Endocrinol Metab,2015,100(10):3651-3659.DOI:10.1210/jc.2015-2632.
[6] Liu Z,Chen Y,Chen G,et al.Impaired glucose metabolism in young offspring of female rats with hypothyroidism[J].J Diabetes Res,2019,2019:4713906.DOI:10.1155/2019/4713906.
[7] Farahani H,Ghasemi A,Roghani M,et al.Effect of neonatal hypothyroidism on carbohydrate metabolism,insulin secretion,and pancreatic islets morphology of adult male offspring in rats[J].J Endocrinol Invest,2013,36(1):44-49.DOI:10.3275/8468.
[8] Aguayo-Mazzucato C,Lee TB Jr,Matzko M,et al.T3 induces both markers of maturation and aging in pancreatic β-cells[J].Diabetes,2018,67(7):1322-1331.DOI:10.2337/db18-0030.
[9] Narasimhan A,Flores RR,Robbins PD,et al.Role of cellular senescence in type II diabetes[J].Endocrinology,2021,162(10):bqab136.DOI:10.1210/endocr/bqab136.
[10] trbk V.Pancreatic thyrotropin releasing hormone and mechanism of insulin secretion[J].Cell Physiol Biochem,2018,50(1):378-384.DOI:10.1159/000494013.
[11] Mulla CM,Geras-Raaka E,Raaka BM,et al.High levels of thyrotropin-releasing hormone receptors activate programmed cell death in human pancreatic precursors[J].Pancreas,2009,38(2):197-202.DOI:10.1097/MPA.0b013e31818d14a8.
[12] Bacová Z,Najvirtová M,Krizanová O,et al.Effect of neonatal streptozotocin and thyrotropin-releasing hormone treatments on insulin secretion in adult rats[J].Gen Physiol Biophys,2005,24(2):181-197.
[13] Yan Y,Niu Z,Sun C,et al.Hepatic thyroid hormone signalling modulates glucose homeostasis through the regulation of GLP-1 production via bile acid-mediated FXR antagonism[J].Nat Commun,2022,13(1):6408.DOI:10.1038/s41467-022-34258-w.
[14] Lehmphul I,Hoefig CS,Köhrle J.3-Iodothyronamine reduces insulin secretion in vitro via a mitochondrial mechanism[J].Mol Cell Endocrinol,2018,460:219-228.DOI:10.1016/j.mce.2017.07.026.
[15] Lyu J,Imachi H,Yoshimoto T,et al.Thyroid stimulating hormone stimulates the expression of glucose transporter 2 via its receptor in pancreatic β cell line,INS-1 cells[J].Sci Rep,2018,8(1):1986.DOI:10.1038/s41598-018-20449-3.
[16] Yang Y,Chen Y,Chen J,et al.The adverse effects of thyrotropin absence on pancreatic β cell function in mice[J].J Diabetes Res,2019,2019:9536032.DOI:10.1155/2019/9536032.
[17] Yamada M,Saga Y,Shibusawa N,et al.Tertiary hypothyroidism and hyperglycemia in mice with targeted disruption of the thyrotropin-releasing hormone gene[J].Proc Natl Acad Sci U S A,1997,94(20):10862-10867.DOI:10.1073/pnas.94.20.10862.
[18] Najvirtová M,Bacová Z,Mátéffyová A,et al.A role of thyrotropin-releasing hormone in insulin secretion by isolated rat pancreatic islets[J].Pflugers Arch,2005,449(6):547-552.DOI:10.1007/s00424-004-1362-6.
[19] Jörns A,Sennholz C,Naujok O,et al.Beta cell mass regulation in the rat pancreas through glucocorticoids and thyroid hormones[J].Pancreas,2010,39(8):1167-1172.DOI:10.1097/MPA.0b013e3181dfce4f.
[20] Kim TK,Lee JS,Jung HS,et al.Triiodothyronine induces proliferation of pancreatic β-cells through the MAPK/ERK pathway[J].Exp Clin Endocrinol Diabetes,2014,122(4):240-245.DOI:10.1055/s-0034-1367060.
[21] Katz LS,Argmann C,Lambertini L,et al.T3 and glucose increase expression of phosphoenolpyruvate carboxykinase(PCK1)leading to increased β-cell proliferation[J].Mol Metab,2022,66:101646.DOI:10.1016/j.molmet.2022.101646.
[22] Luo L,Luo JZ,Jackson IM.Thyrotropin-releasing hormone(TRH)reverses hyperglycemia in rat[J].Biochem Biophys Res Commun,2008,374(1):69-73.DOI:10.1016/j.bbrc.2008.06.111.
[23] Yano N,Luo L.Effect of thyrotropin releasing hormone(TRH)on gene expressions in rat pancreas:approach by microarray hybridization[J].JOP,2004,5(4):193-204.
[24] Song E,Koo MJ,Noh E,et al.Risk of diabetes in patients with long-standing Graves' disease:a longitudinal study[J].Endocrinol Metab(Seoul),2021,36(6):1277-1286.DOI:10.3803/EnM.2021.1251.
[25] Roa Dueñas OH,Van der Burgh AC,Ittermann T,et al.Thyroid function and the risk of prediabetes and type 2 diabetes[J].J Clin Endocrinol Metab,2022,107(6):1789-1798.DOI:10.1210/clinem/dgac006.
[26] Li Q,Lu M,Wang NJ,et al.Relationship between free thyroxine and islet beta-cell function in euthyroid subjects[J].Curr Med Sci,2020,40(1):69-77.DOI:10.1007/s11596-020-2148-6.
[27] Vamshidhar IS,Rani SSS.A study of association of thyroid dysfunctions in patients with type 2 diabetes mellitus[J].Maedica(Bucur),2020,15(2):169-173.DOI:10.26574/maedica.2020.15.2.169.
[28] Jun JE,Jin SM,Jee JH,et al.TSH increment and the risk of incident type 2 diabetes mellitus in euthyroid subjects[J].Endocrine,2017,55(3):944-953.DOI:10.1007/s12020-016-1221-1.
[29] Rong F,Dai H,Wu Y,et al.Association between thyroid dysfunction and type 2 diabetes:a meta-analysis of prospective observational studies[J].BMC Med,2021,19(1):257.DOI:10.1186/s12916-021-02121-2.
相似文献/References:
[1]朱萍,卫红艳,王坤玲,等.Graves病甲状腺功能亢进症性肝损害的
相关因素分析[J].国际内分泌代谢杂志,2017,37(03):164.[doi:10.3760/cma.j.issn.1673-4157.2017.03.005]
Zhu Ping,Wei Hongyan,Wang Kunling,et al.Related factors of hyperthyroidism-related liver dysfunction in Graves' disease[J].International Journal of Endocrinology and Metabolism,2017,37(06):164.[doi:10.3760/cma.j.issn.1673-4157.2017.03.005]
[2]郑仁东 张会峰 胡咏新 曹雯 曹琳 孙洪平 褚晓秋 刘克冕 刘超.男性2型糖尿病患者甲状腺结节
与内分泌激素的相关性研究[J].国际内分泌代谢杂志,2018,38(04):222.[doi:10.3760/cma.j.issn.1673-4157.2018.04.002]
Zheng Rendong,Zhang Huifeng,Hu Yongxin,et al.Association of thyroid nodules with endocrine hormones in male patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2018,38(06):222.[doi:10.3760/cma.j.issn.1673-4157.2018.04.002]
[3]刘燕晶 张帆.甲状腺功能亢进症性肝损害的发生机制[J].国际内分泌代谢杂志,2019,39(01):34.[doi:10.3760/cma.j.issn.1673-4157.2019.01.008]
Liu Yanjing,Zhang Fan.The pathogenesis of liver damage of hyperthyroidism[J].International Journal of Endocrinology and Metabolism,2019,39(06):34.[doi:10.3760/cma.j.issn.1673-4157.2019.01.008]
[4]周鹏 张少红 韦晓 陈国芳 刘超.季节性变化对甲状腺激素的影响[J].国际内分泌代谢杂志,2019,39(05):349.[doi:10.3760/cma.j.issn.1673-4157.2019.05.015]
Zhou Peng,Zhang Shaohong,Wei Xiao,et al.Effects of seasonal changes on thyroid hormones[J].International Journal of Endocrinology and Metabolism,2019,39(06):349.[doi:10.3760/cma.j.issn.1673-4157.2019.05.015]
[5]张小改 陈国芳 徐书杭 张芳 刘超.甲状腺激素与肥胖:孰因孰果?[J].国际内分泌代谢杂志,2020,40(02):129.[doi:10.3760/cma.j.issn.1673-4157.2020.02.014]
Zhang Xiaogai,Chen Guofang,Xu Shuhang,et al.Thyroid hormone and obesity:cause or consequence?[J].International Journal of Endocrinology and Metabolism,2020,40(06):129.[doi:10.3760/cma.j.issn.1673-4157.2020.02.014]
[6]应瑞雪,艾李雅,章诗琪,等.2型糖尿病患者血清正常范围的甲状腺激素水平与肌少症的相关性研究[J].国际内分泌代谢杂志,2022,42(02):114.[doi:10.3760/cma.j.cn121383-20200307-03016]
Ying Ruixue,Ai Liya,Zhang shiqi,et al.Correlation between normal serum thyroid hormone levels and sarcopenia in patients with type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2022,42(06):114.[doi:10.3760/cma.j.cn121383-20200307-03016]
[7]曾晓娇,田玲,孙毅娜.Allan-Herndon-Dudley综合征诊疗现状[J].国际内分泌代谢杂志,2023,43(04):336.[doi:10.3760/cma.j.cn121383-20220926-09047]
Zeng Xiaojiao,Tian Ling,Sun Yina.Diagnosis and treatment of Allan-Herndon-Dudley syndrome[J].International Journal of Endocrinology and Metabolism,2023,43(06):336.[doi:10.3760/cma.j.cn121383-20220926-09047]